150 related articles for article (PubMed ID: 16414216)
41. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study.
Ferrazzi E; Zupi E; Leone FP; Savelli L; Omodei U; Moscarini M; Barbieri M; Cammareri G; Capobianco G; Cicinelli E; Coccia ME; Donarini G; Fiore S; Litta P; Sideri M; Solima E; Spazzini D; Testa AC; Vignali M
Am J Obstet Gynecol; 2009 Mar; 200(3):235.e1-6. PubMed ID: 19027096
[TBL] [Abstract][Full Text] [Related]
42. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer.
Smuc T; Rizner TL
Mol Cell Endocrinol; 2009 Mar; 301(1-2):74-82. PubMed ID: 18930784
[TBL] [Abstract][Full Text] [Related]
43. Proliferation profile of endometrial polyps in post-menopausal women.
Maia H; Maltez A; Athayde C; Coutinho EM
Maturitas; 2001 Dec; 40(3):273-81. PubMed ID: 11731188
[TBL] [Abstract][Full Text] [Related]
44. Pregnancy rates after hysteroscopic polypectomy depending on the size or number of the polyps.
Stamatellos I; Apostolides A; Stamatopoulos P; Bontis J
Arch Gynecol Obstet; 2008 May; 277(5):395-9. PubMed ID: 17851673
[TBL] [Abstract][Full Text] [Related]
45. Hysteroscopic resection of symptomatic and asymptomatic endometrial polyps.
Lieng M; Qvigstad E; Sandvik L; Jørgensen H; Langebrekke A; Istre O
J Minim Invasive Gynecol; 2007; 14(2):189-94. PubMed ID: 17368255
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women.
Reinier KS; Vacek PM; Geller BM
Breast Cancer Res Treat; 2007 Jul; 103(3):343-8. PubMed ID: 17063272
[TBL] [Abstract][Full Text] [Related]
47. To study the significance of apoptotic enzyme granzyme H in breast cancer patients.
Razvi NZ; Khurshid R; Nagra SA
J Ayub Med Coll Abbottabad; 2008; 20(1):84-6. PubMed ID: 19024195
[TBL] [Abstract][Full Text] [Related]
48. Endometrial polyps detected at ultrasound and rate of malignancy.
Uglietti A; Mazzei C; Deminico N; Somigliana E; Vercellini P; Fedele L
Arch Gynecol Obstet; 2014 Apr; 289(4):839-43. PubMed ID: 24091484
[TBL] [Abstract][Full Text] [Related]
49. Are diabetes, hypertension, and obesity independent risk factors for endometrial polyps?
Nappi L; Indraccolo U; Di Spiezio Sardo A; Gentile G; Palombino K; Castaldi MA; Spinelli M; Greco P
J Minim Invasive Gynecol; 2009; 16(2):157-62. PubMed ID: 19162559
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical expression of p63 in endometrial polyps: evidence that a basal cell immunophenotype is maintained.
Nogueira AA; Sant'Ana de Almeida EC; Poli Neto OB; Zambelli Ramalho LN; Rosa e Silva JC; Candido dos Reis FJ
Menopause; 2006; 13(5):826-30. PubMed ID: 16912659
[TBL] [Abstract][Full Text] [Related]
51. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
[TBL] [Abstract][Full Text] [Related]
52. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical labelling of steroid receptors in normal and malignant human endometrium.
Mylonas I; Makovitzky J; Friese K; Jeschke U
Acta Histochem; 2009; 111(4):349-59. PubMed ID: 19195687
[TBL] [Abstract][Full Text] [Related]
54. Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer.
Yamazawa K; Hirai M; Fujito A; Nishi H; Terauchi F; Ishikura H; Shozu M; Isaka K
Hum Reprod; 2007 Jul; 22(7):1953-8. PubMed ID: 17449880
[TBL] [Abstract][Full Text] [Related]
55. Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker.
Devetzi M; Scorilas A; Tsiambas E; Sameni M; Fotiou S; Sloane BF; Talieri M
Gynecol Oncol; 2009 Mar; 112(3):531-6. PubMed ID: 19110306
[TBL] [Abstract][Full Text] [Related]
56. Obesity and risk of the less commonly diagnosed subtypes of breast cancer.
Stark A; Schultz D; Kapke A; Nadkarni P; Burke M; Linden M; Raju U
Eur J Surg Oncol; 2009 Sep; 35(9):928-35. PubMed ID: 19121564
[TBL] [Abstract][Full Text] [Related]
57. Effect of ormeloxifene, a selective estrogen receptor modulator, on biomarkers of endometrial receptivity and pinopode development and its relation to fertility and infertility in Indian subjects.
Makker A; Tandon I; Goel MM; Singh M; Singh MM
Fertil Steril; 2009 Jun; 91(6):2298-307. PubMed ID: 18675966
[TBL] [Abstract][Full Text] [Related]
58. Relation between vaginal and endocervical pH in pre- and post-menopausal women.
Murta EF; Filho AC; Barcelos AC
Arch Gynecol Obstet; 2005 Sep; 272(3):211-3. PubMed ID: 15838694
[TBL] [Abstract][Full Text] [Related]
59. Detection of benign intracavitary lesions in postmenopausal women with abnormal uterine bleeding: a prospective comparative study on outpatient hysteroscopy and blind biopsy.
Angioni S; Loddo A; Milano F; Piras B; Minerba L; Melis GB
J Minim Invasive Gynecol; 2008; 15(1):87-91. PubMed ID: 18262151
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical detection of receptors for oestrogen and progesterone in endometrial glands and stroma during the oestrous cycle in Nelore (Bos taurus indicus) cows.
Martin I; Torres Neto R; Oba E; Buratini J; Binelli M; Laufer-Amorim R; Ferreira JC
Reprod Domest Anim; 2008 Aug; 43(4):415-21. PubMed ID: 18179635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
